Orthofix Medical Inc (OFIX) Shares Sold by Meeder Asset Management Inc.

Meeder Asset Management Inc. lessened its stake in shares of Orthofix Medical Inc (NASDAQ:OFIX) by 37.6% during the 3rd quarter, Holdings Channel reports. The firm owned 8,373 shares of the medical device company’s stock after selling 5,047 shares during the quarter. Meeder Asset Management Inc.’s holdings in Orthofix Medical were worth $485,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently added to or reduced their stakes in the company. First Quadrant L P CA purchased a new stake in Orthofix Medical during the 3rd quarter worth approximately $122,000. Itau Unibanco Holding S.A. purchased a new stake in Orthofix Medical during the 2nd quarter worth approximately $224,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS purchased a new stake in Orthofix Medical during the 2nd quarter worth approximately $227,000. Hartford Investment Management Co. purchased a new stake in shares of Orthofix Medical in the 2nd quarter valued at $269,000. Finally, United Services Automobile Association boosted its holdings in shares of Orthofix Medical by 37.9% in the 2nd quarter. United Services Automobile Association now owns 5,908 shares of the medical device company’s stock valued at $336,000 after acquiring an additional 1,623 shares during the last quarter. 92.64% of the stock is currently owned by institutional investors.

In related news, CEO Brad Mason sold 2,500 shares of the stock in a transaction on Wednesday, September 5th. The shares were sold at an average price of $53.02, for a total transaction of $132,550.00. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Luke T. Faulstick sold 8,450 shares of the stock in a transaction on Friday, November 2nd. The stock was sold at an average price of $61.05, for a total transaction of $515,872.50. Following the sale, the director now directly owns 7,129 shares in the company, valued at $435,225.45. The disclosure for this sale can be found here. Insiders sold a total of 28,343 shares of company stock worth $1,690,376 over the last ninety days. Insiders own 5.60% of the company’s stock.

Several analysts have recently commented on OFIX shares. TheStreet raised shares of Orthofix Medical from a “c+” rating to a “b-” rating in a report on Monday, September 10th. BidaskClub downgraded shares of Orthofix Medical from a “strong-buy” rating to a “buy” rating in a report on Wednesday, September 12th. Cantor Fitzgerald upped their price objective on shares of Orthofix Medical to $66.00 and gave the company an “overweight” rating in a report on Tuesday, August 7th. Finally, Zacks Investment Research downgraded shares of Orthofix Medical from a “hold” rating to a “sell” rating in a report on Thursday, August 9th. Four equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. Orthofix Medical presently has a consensus rating of “Buy” and an average target price of $67.67.

OFIX stock opened at $61.68 on Friday. The firm has a market capitalization of $1.18 billion, a PE ratio of 34.08, a price-to-earnings-growth ratio of 3.67 and a beta of 0.30. Orthofix Medical Inc has a 12 month low of $50.41 and a 12 month high of $63.57.

Orthofix Medical (NASDAQ:OFIX) last released its quarterly earnings data on Monday, October 29th. The medical device company reported $0.43 EPS for the quarter, beating the consensus estimate of $0.34 by $0.09. The business had revenue of $111.70 million for the quarter, compared to the consensus estimate of $110.65 million. Orthofix Medical had a net margin of 1.45% and a return on equity of 10.97%. The business’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same period in the prior year, the firm earned $0.42 EPS. As a group, sell-side analysts predict that Orthofix Medical Inc will post 1.75 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece was first posted by WKRB News and is the property of of WKRB News. If you are viewing this piece on another publication, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark legislation. The original version of this piece can be viewed at https://www.wkrb13.com/2018/11/11/orthofix-medical-inc-ofix-shares-sold-by-meeder-asset-management-inc.html.

Orthofix Medical Company Profile

Orthofix Medical Inc, a medical device company, provides musculoskeletal healing products and value-added services worldwide. It operates through four segments: BioStim, Extremity Fixation, Spine Fixation, and Biologics. The BioStim segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to enhance fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spine fractures.

Read More: Should You Consider an Index Fund?

Want to see what other hedge funds are holding OFIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Orthofix Medical Inc (NASDAQ:OFIX).

Institutional Ownership by Quarter for Orthofix Medical (NASDAQ:OFIX)

Receive News & Ratings for Orthofix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply